This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Inventor Spotlight: Richard Lu and His Innovations in Gene Delivery Systems
Introduction: Richard Lu, a prominent inventor based in Jamaica Plain, MA, has made significant contributions to the field of genetic research with his invention focused on lentiviral vectors. His innovative approach has the potential to enhance gene delivery systems, particularly in therapeutic applications.
Latest Patents: Richard Lu holds a patent for "Episomally Replicating Lentiviral Vectors." This invention revolves around a lentiviral vector system designed for the episomal replication of a desired gene. The system comprises multiple vectors, including a first vector with a lentiviral gag gene, a second vector containing an env gene, and a modified pol gene that encodes a lentiviral pol protein, which has been altered to prevent integration. The unique design ensures that the gag, pol, and envelope proteins are present on separate vectors, optimizing the packaging and function of the lentiviral RNA.
Career Highlights: Richard Lu is currently affiliated with the Dana-Farber Cancer Institute Inc., a leading organization in cancer research and treatment. His work there highlights his commitment to advancing medical science and improving treatment options for patients.
Collaborations: Throughout his career, Richard has collaborated with esteemed colleagues, including Alan Engelman and Wolfgang Hofmann. These partnerships have fostered an environment of innovation and shared knowledge, enhancing the potential impact of his inventions in the field.
Conclusion: Richard Lu's contributions to the development of episomally replicating lentiviral vectors illustrate the importance of innovations in genetic research. His work not only sheds light on potential therapies but also emphasizes the collaborative nature of scientific advancement. As the field continues to evolve, the impact of Richard's inventions will undoubtedly be felt for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
